文献速递慢性肾脏病

基于人群的队列研究显示白蛋白尿与抑郁患病率较高相关:马斯特里赫特研究

Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

在荷兰南部一项基于人群的队列研究基线调查中,纳入40至75岁个体,分析白蛋白尿和估算肾小球滤过率(eGFR)与抑郁症状及抑郁发作的横断面关联。尿白蛋白排泄(UAE)15-<30 mg/24 h者相较<15 mg/24 h者,轻或重抑郁发作的比值比为2.13(95%CI 1.36-3.36);UAE≥30 mg/24 h者为1.81(95%CI 1.10-2.98)。eGFR与抑郁发作无关,结论提出未来需纵向研究验证关联方向。

要点

  • UAE 15-<30 mg/24 h者轻或重抑郁发作比值比为2.13(95%CI 1.36-3.36)。
  • UAE≥30 mg/24 h者轻或重抑郁发作比值比为1.81(95%CI 1.10-2.98)。
  • eGFR与轻或重抑郁发作无显著关联。

核心结论

  • 白蛋白尿与抑郁症状及抑郁发作相关,即使在未满足慢性肾脏病(CKD)诊断标准的UAE水平亦如此。
  • 未来需纵向研究检验该关联的方向及白蛋白尿能否作为识别抑郁风险个体的生物标志物。

研究设计与样本

  • 基于人群的队列研究基线横断面分析,在荷兰南部于2010年11月至2013年9月开展。
  • 分析UAE与抑郁症状及抑郁发作的样本分别为2872人和3083人,年龄40至75岁。
  • UAE取两次24小时尿液采集的平均值,eGFR用基于肌酐和胱抑素C的慢性肾脏病流行病学协作组(CKD-EPI)方程计算。
  • 抑郁症状采用9项患者健康问卷(PHQ-9)评估,轻或重抑郁发作采用MINI国际神经精神访谈评估。

主要发现

  • 总人群中5.4%存在轻或重抑郁发作。
  • UAE<15 mg/24 h者占81.2%,15-<30 mg/24 h者占10.3%,≥30 mg/24 h者占8.6%。
  • 以UAE<15 mg/24 h为参照,校正潜在混杂因素后,UAE 15-<30 mg/24 h者轻或重抑郁发作的比值比为2.13(95%CI 1.36-3.36)。
  • UAE≥30 mg/24 h者轻或重抑郁发作的比值比为1.81(95%CI 1.10-2.98)。
  • 平均eGFR为88.2 ± 14.7 mL/min/1.73 m2,eGFR与轻或重抑郁发作无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression is common in individuals with chronic kidney disease (CKD). However, data on the association of albuminuria, which together with reduced estimated glomerular filtration rate (eGFR) defines CKD, with depression are scarce and conflicting. In addition, it is not clear when in the course from normal kidney function to CKD the association with depression appears. METHODS: We examined the cross-sectional associations of albuminuria and eGFR with depressive symptoms and depressive episodes in 2872 and 3083 40- to 75-year-old individuals, respectively, who completed the baseline survey of an ongoing population-based cohort study conducted in the southern part of The Netherlands between November 2010 and September 2013. Urinary albumin excretion (UAE) was the average UAE in two 24-h urine collections and eGFR was calculated with the Chronic Kidney Disease Epidemiology Collaboration equation based on creatinine and cystatin C. Depressive symptoms were assessed with the 9-item Patient Health Questionnaire (PHQ-9) and the presence of a minor or major depressive episode was assessed with the MINI-International Neuropsychiatric Interview. RESULTS: In total, 5.4% had a minor or major depressive episode. UAE was <15 mg/24 h in 81.2%, 15-<30 mg/24 h in 10.3% and ≥30 mg/24 h in 8.6%. In a multivariable logistic regression analysis adjusted for potential confounders, and with UAE <15 mg/24 h as reference category, the odds ratio for a minor or major depressive episode was 2.13 [95% confidence interval (CI) 1.36-3.36] for UAE 15-<30 mg/24 h and 1.81 (95% CI 1.10-2.98) for UAE ≥30 mg/24 h. The average eGFR was 88.2 ± 14.7 mL/min/1.73 m2. eGFR was not associated with the presence of a minor or major depressive episode. Results were similar when we assessed associations with depressive symptoms or clinically relevant depressive symptoms (PHQ-9 score ≥10). CONCLUSIONS: Albuminuria was associated with depressive symptoms and depressive episodes, even at levels of UAE that do not fulfil the CKD criteria. Future longitudinal studies should examine the direction of this association and whether albuminuria could serve as a biomarker to identify individuals at risk of depression.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Martens RJH, Kooman JP, Stehouwer CDA, et al. Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study. Nephrol Dial Transplant. 2018. PMID: 27965374. doi:10.1093/ndt/gfw377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。